ACE‑083 – 1 mg (Roledapam)
Core Identifiers
- Name: ACE‑083
- Synonyms: ActRIIB ligand trap, investigational myostatin inhibitor
- CAS Number: 81080-10-6
- Quantity: 1 mg (lyophilised powder)
- Formulation: Recombinant fusion protein
Key Features
- Purity: ≥ 95–98% (HPLC‑verified, depending on supplier)
- Endotoxin: ≤ 5 EU/mg
- Form: Freeze‑dried (lyophilised) protein powder
- Documentation: Certificate of Analysis (COA) supplied with every lot
- Mechanism: Functions as a ligand trap for ActRIIB, binding myostatin and related TGF‑β family proteins to promote muscle growth
Protein Information
- Structure: Recombinant fusion protein designed to sequester ligands of activin receptor type IIB
- Classification: Synthetic biologic for research workflows
• Myostatin inhibition studies
• Muscle wasting and neuromuscular disease models
• Duchenne muscular dystrophy (DMD) research
Storage and Stability
- Long‑term: –20 °C, dry and desiccated
- Short‑term: Stable at 2–8 °C
- Handling Note: Avoid repeated freeze–thaw cycles
Intended Use
- For laboratory research only
- Not for human or veterinary use
- Not approved for diagnostic, therapeutic, or medical applications
- Must be handled using appropriate laboratory safety practices
Why Choose ACE‑083 – 1 mg
- Unique mechanism targeting myostatin and activin pathways
- High purity suitable for sensitive experimental systems
- Full batch traceability with COA included
- Lyophilised for extended stability
| Weight | 100 g |
|---|---|
| Dimensions | 1 × 1 × 3 cm |
